Lv71
4970 积分 2021-04-01 加入
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
1天前
已完结
Management of Angina Pectoris
3天前
求助中
Heart rate-lowering drugs and outcomes in hypertension and/or cardiovascular disease: a meta-analysis
3天前
已完结
Cost-Effectiveness and Price Threshold Analysis of Tafolecimab in Chinese Patients with Elevated LDL Cholesterol Despite Statin Therapy
5天前
已完结
The Efficacy of Tafolecimab in Chinese Patients with Hypercholesterolemia: A Systematic Review and Meta-analysis
5天前
已完结
Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review
5天前
已完结
Tafolecimab: First Approval
5天前
已完结
心血管-肾脏-代谢综合征患者的综合管理中国专家共识
9天前
已完结
Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA phase 3 randomized clinical trial
11天前
已完结
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
19天前
已完结
皖公网安备34019202002308
